You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Ramucirumab, Avelumab, and Paclitaxel as second-line treatment in esophagogastric adenocarcinoma
:
the phase 2 RAP (AIO-STO-0218) nonrandomized controlled trial